title: [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
authors: P
authors: P
authors: Boulot
authors: F
authors: F
authors: Pratlong
authors: P
authors: P
authors: Sarda
authors: F
authors: F
authors: Deschamps
authors: B
authors: B
authors: Hedon
authors: F
authors: F
authors: Laffargue
authors: J L
authors: JL
authors: Viala
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011295:Prenatal Care; D011739:Pyrimethamine / Q000008:administration & dosage*; D013411:Sulfadiazine / Q000008:administration & dosage*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy*
chemical_list: D013411:Sulfadiazine; D011739:Pyrimethamine
vernacular_title: Limites du traitement prénatal de la toxoplasmose congénitale par l'association sulfadiazine-pyriméthamine.